US5346702A
(en)
*
|
1992-12-04 |
1994-09-13 |
Sterling Winthrop Inc. |
Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
|
US5298262A
(en)
*
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
US5336507A
(en)
*
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
US5525327A
(en)
*
|
1994-04-14 |
1996-06-11 |
Sterling Winthrop Inc. |
Polymeric x-ray contrast compositions containing iodinated polymeric beads and microcrystaline cellulose
|
US5368837A
(en)
*
|
1994-04-14 |
1994-11-29 |
Sterling Winthrop Inc. |
X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative
|
US6645463B1
(en)
*
|
1994-05-16 |
2003-11-11 |
The Board Of Regents Of The University Of Michigan |
Blood-pool selective carrier for lipophilic imaging agents
|
US5628981A
(en)
*
|
1994-12-30 |
1997-05-13 |
Nano Systems L.L.C. |
Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents
|
US5466440A
(en)
*
|
1994-12-30 |
1995-11-14 |
Eastman Kodak Company |
Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
|
ATE274341T1
(de)
*
|
1995-02-24 |
2004-09-15 |
Elan Pharma Int Ltd |
Nanopartikel-dispersionen enthaltende aerosole
|
US5565188A
(en)
*
|
1995-02-24 |
1996-10-15 |
Nanosystems L.L.C. |
Polyalkylene block copolymers as surface modifiers for nanoparticles
|
US5962380A
(en)
*
|
1995-06-06 |
1999-10-05 |
Chevron Chemical Company Llc |
Fluorocarbon elastomer compatibility improving agent having wear inhibition effect
|
US5766629A
(en)
|
1995-08-25 |
1998-06-16 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
AU743917B2
(en)
*
|
1996-08-22 |
2002-02-07 |
Rtp Pharma Corporation |
Compositions comprising microparticles of water-insoluble substances
|
WO1998007414A1
(en)
*
|
1996-08-22 |
1998-02-26 |
Research Triangle Pharmaceuticals Ltd. |
Compositions comprising microparticles of water-insoluble substances and method for preparing same
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
GB9705340D0
(en)
*
|
1997-03-14 |
1997-04-30 |
Nycomed Imaging As |
Compositions
|
WO1998048847A1
(en)
*
|
1997-04-25 |
1998-11-05 |
Nycomed Imaging As |
Nanoparticle composition containing iodinated x-ray contrast agent as stabilizer for thermal sterilization
|
GB9712981D0
(en)
*
|
1997-06-19 |
1997-08-27 |
Nycomed Imaging As |
Compositions
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
US20010003580A1
(en)
*
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US6337092B1
(en)
|
1998-03-30 |
2002-01-08 |
Rtp Pharma Inc. |
Composition and method of preparing microparticles of water-insoluble substances
|
JP4709378B2
(ja)
|
1998-03-30 |
2011-06-22 |
オバン・エナジー・リミテッド |
水不溶性物質のマイクロ粒子を製造するための組成物及び方法
|
AU764001B2
(en)
|
1998-05-29 |
2003-08-07 |
Skyepharma Canada Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
IL142896A0
(en)
*
|
1998-11-02 |
2002-04-21 |
Elan Corp Plc |
Multiparticulate modified release composition
|
US20070160675A1
(en)
*
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
CA2349203C
(en)
|
1998-11-20 |
2013-05-21 |
Rtp Pharma Inc. |
Dispersible phospholipid stabilized microparticles
|
US6309596B1
(en)
*
|
1998-12-15 |
2001-10-30 |
Bausch & Lomb Incorporated |
Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by a poloxamine
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
CN1174741C
(zh)
*
|
1999-09-21 |
2004-11-10 |
Rtp药品公司 |
生物活性物质的表面改性微粒组合物
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
EP1341521B1
(en)
*
|
2000-11-20 |
2009-01-07 |
Elan Pharma International Limited |
Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US6897196B1
(en)
*
|
2001-02-07 |
2005-05-24 |
The Regents Of The University Of California |
pH sensitive lipids based on ortho ester linkers, composition and method
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
US20030087308A1
(en)
*
|
2001-06-22 |
2003-05-08 |
Elan Pharma International Limited |
Method for high through put screening using a small scale mill or microfluidics
|
US7687053B2
(en)
*
|
2001-08-20 |
2010-03-30 |
Boston Scientific Scimed, Inc. |
Embolic compositions with non-cyanoacrylate rheology modifying agents
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
DE60217367T2
(de)
*
|
2001-09-19 |
2007-10-18 |
Elan Pharma International Ltd. |
Nanopartikelzusammensetzungen enthaltend insulin
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
JP2005504090A
(ja)
|
2001-09-26 |
2005-02-10 |
バクスター・インターナショナル・インコーポレイテッド |
分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
|
ATE371442T1
(de)
*
|
2001-10-12 |
2007-09-15 |
Elan Pharma Int Ltd |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
US20030152519A1
(en)
*
|
2001-11-07 |
2003-08-14 |
Reinhard Koenig |
Methods for vascular imaging using nanoparticulate contrast agents
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
AU2003210517A1
(en)
*
|
2002-02-04 |
2003-09-02 |
Elan Pharma International, Ltd. |
Drug nanoparticles with lysozyme surface stabiliser
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
WO2003080023A2
(en)
*
|
2002-03-20 |
2003-10-02 |
Elan Pharma International Limited |
Fast dissolving dosage forms having reduced friability
|
DE60309300T3
(de)
*
|
2002-03-20 |
2011-02-24 |
Elan Pharma International Ltd. |
Nanopartikelzusammensetzungen von angiogeneseinhibitoren
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
AU2003230885A1
(en)
|
2002-04-12 |
2003-10-27 |
Elan Pharma International Ltd. |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US20040018242A1
(en)
*
|
2002-05-06 |
2004-01-29 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
CA2488498A1
(en)
*
|
2002-06-10 |
2003-12-18 |
Elan Pharma International Limited |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
CN100518831C
(zh)
*
|
2002-08-15 |
2009-07-29 |
刘云清 |
固体纳米药物及其制备方法
|
US7713551B2
(en)
*
|
2002-09-11 |
2010-05-11 |
Elan Pharma International Ltd. |
Gel stabilized nanoparticulate active agent compositions
|
JP2006501936A
(ja)
*
|
2002-10-04 |
2006-01-19 |
エラン ファーマ インターナショナル,リミティド |
固体ナノ粒子活性薬剤のガンマ線照射
|
CA2504610C
(en)
*
|
2002-11-12 |
2012-02-21 |
Elan Pharma International Ltd. |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
DK1593091T3
(da)
|
2003-01-25 |
2013-10-28 |
Seno Medical Instr Inc |
Optoakustisk afbildning med høj kontrast ved anvendelse af ikke-sfæriske nanopartikler
|
EP1587499A1
(en)
*
|
2003-01-31 |
2005-10-26 |
Elan Pharma International Limited |
Nanoparticulate topiramate formulations
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
JP2007501683A
(ja)
*
|
2003-05-22 |
2007-02-01 |
エラン ファーマ インターナショナル リミテッド |
γ線照射によるナノ粒子活性物質分散体の滅菌法
|
DE602004018150D1
(de)
*
|
2003-08-08 |
2009-01-15 |
Elan Pharma Int Ltd |
Neue metaxalon-zusammensetzungen
|
JP2005170923A
(ja)
*
|
2003-10-21 |
2005-06-30 |
Konica Minolta Medical & Graphic Inc |
リポソーム含有x線造影剤およびその製造方法
|
CA2544627A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
US7588751B2
(en)
*
|
2004-07-21 |
2009-09-15 |
Konica Minolta Medical & Graphic, Inc. |
Liposome-containing radiographic contrast medium and preparation method thereof
|
WO2006016468A1
(ja)
*
|
2004-08-11 |
2006-02-16 |
Konica Minolta Medical & Graphic, Inc. |
リポソーム含有製剤の製造方法
|
US20090155331A1
(en)
*
|
2005-11-16 |
2009-06-18 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
US7910577B2
(en)
*
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
MX2007007342A
(es)
*
|
2004-12-15 |
2007-12-11 |
Elan Pharma Int Ltd |
Formulaciones de tacrolimus nanoparticuladas.
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
BRPI0606434A2
(pt)
*
|
2005-01-06 |
2009-06-30 |
Elan Pharma Int Ltd |
formulações de candesartana nanoparticulada
|
EP2353590A1
(en)
*
|
2005-02-15 |
2011-08-10 |
Elan Pharma International Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
JP2008531721A
(ja)
*
|
2005-03-03 |
2008-08-14 |
エラン・ファルマ・インターナショナル・リミテッド |
複素環式アミド誘導体のナノ粒子状組成物
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
AU2006225117A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Elan Pharma International Limited |
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
|
CN101198316A
(zh)
*
|
2005-03-17 |
2008-06-11 |
伊兰制药国际有限公司 |
纳米微粒双膦酸盐组合物
|
AU2006226887A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations
|
CA2603084A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
JP2008535924A
(ja)
*
|
2005-04-12 |
2008-09-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子キナゾリン誘導体製剤
|
WO2006110809A2
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
CN101212954A
(zh)
*
|
2005-05-10 |
2008-07-02 |
伊兰制药国际有限公司 |
纳米粒氯吡格雷制剂
|
WO2006132752A1
(en)
*
|
2005-05-10 |
2006-12-14 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
BRPI0614080A2
(pt)
*
|
2005-05-16 |
2017-07-25 |
Elan Pharma Int Ltd |
Composição e método para a preparação de uma cefalosporina nanoparticulada, para o tratamento de doença bacteriana e para a prevenção e/ou tratamento de osteoporose
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
EA015102B1
(ru)
*
|
2005-06-03 |
2011-06-30 |
Элан Фарма Интернэшнл Лтд. |
Препараты наночастиц мезилата иматиниба
|
AU2006309295B2
(en)
*
|
2005-06-03 |
2012-04-26 |
Elan Pharma International Limited |
Nanoparticulate acetaminophen formulations
|
WO2006133045A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
DE112006001606T5
(de)
|
2005-06-08 |
2009-07-09 |
Elan Pharma International Ltd., Athlone |
Nanopartikuläre und eine kontrollierte Freisetzung aufweisende Zusammensetzung, die Cefditoren umfassen
|
ATE446742T1
(de)
*
|
2005-06-09 |
2009-11-15 |
Elan Pharma Int Ltd |
Nanopartikuläre ebastinformulierungen
|
JP2008543843A
(ja)
*
|
2005-06-13 |
2008-12-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子クロピドグレル及びアスピリンの配合製剤
|
US20100221327A1
(en)
*
|
2005-06-15 |
2010-09-02 |
Elan Pharma International Limited |
Nanoparticulate azelnidipine formulations
|
JP2009500356A
(ja)
*
|
2005-07-07 |
2009-01-08 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子クラリスロマイシン製剤
|
WO2007033239A2
(en)
*
|
2005-09-13 |
2007-03-22 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
EP1933814A2
(en)
*
|
2005-09-15 |
2008-06-25 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
EP2040675A1
(en)
*
|
2006-05-30 |
2009-04-01 |
Elan Pharma International Limited |
Nanoparticulate posaconazole formulations
|
JP2009543797A
(ja)
*
|
2006-07-10 |
2009-12-10 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子ソラフェニブ製剤
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
AU2008278605A1
(en)
*
|
2007-07-26 |
2009-01-29 |
Nanoscan Imaging, Llc |
Methods for imaging using improved nanoparticulate contrast agents
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
WO2009117401A2
(en)
*
|
2008-03-21 |
2009-09-24 |
Elan Pharama International Limited |
Compositions for site-specific delivery of imatinib and methods of use
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
US20120065221A1
(en)
|
2009-02-26 |
2012-03-15 |
Theraquest Biosciences, Inc. |
Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
|
EP2435027B1
(en)
|
2009-05-27 |
2016-10-05 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate meloxicam compositions
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
US8933001B2
(en)
|
2010-03-31 |
2015-01-13 |
Chevron Oronite Company Llc |
Method for improving fluorocarbon elastomer seal compatibility
|
US9150811B2
(en)
|
2010-03-31 |
2015-10-06 |
Cherron Oronite Company LLC |
Method for improving copper corrosion performance
|
US8993496B2
(en)
|
2010-03-31 |
2015-03-31 |
Chevron Oronite Company Llc |
Method for improving fluorocarbon elastomer seal compatibility
|
US8901050B2
(en)
|
2010-03-31 |
2014-12-02 |
Chevron Oronite Company Llc |
Method for improving copper corrosion performance
|
US8716202B2
(en)
|
2010-12-14 |
2014-05-06 |
Chevron Oronite Company Llc |
Method for improving fluorocarbon elastomer seal compatibility
|
EP2873670A1
(en)
|
2013-11-14 |
2015-05-20 |
Bayer Pharma Aktiengesellschaft |
Bis azainositol zirconium complexes for X-ray imaging
|
WO2016178876A2
(en)
|
2015-05-01 |
2016-11-10 |
Cocrystal Pharma, Inc. |
Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
|